As of April 16, 2025, Aldeyra Therapeutics (ALDX) has a market cap of $0.13 billion USD. According to our data, Aldeyra Therapeutics is ranked No.7355 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.13 B |
-55.79%
|
Dec 31, 2024 | $0.30 B |
42.17%
|
Dec 29, 2023 | $0.21 B |
-49.57%
|
Dec 30, 2022 | $0.41 B |
74.00%
|
Dec 31, 2021 | $0.24 B |
-41.69%
|
Dec 31, 2020 | $0.41 B |
18.07%
|
Dec 31, 2019 | $0.35 B |
-30.00%
|
Dec 31, 2018 | $0.49 B |
22.06%
|
Dec 29, 2017 | $0.40 B |
27.10%
|
Dec 30, 2016 | $0.32 B |
-21.09%
|
Dec 31, 2015 | $0.40 B |
-6.09%
|
Dec 31, 2014 | $0.43 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Apellis Pharmaceuticals
APLS
|
$2.38 B |
-0.000 M
|
![]() USA
|
![]() Kala Pharmaceuticals
KALA
|
$22.78 M |
0.000 M
|
![]() USA
|
![]() Ocular Therapeutix
OCUL
|
$1.20 B |
-0.000 M
|
![]() USA
|
![]() EyePoint Pharmaceuticals
EYPT
|
$0.39 B |
-0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Alcon
ALC
|
$45.22 B |
-0.002 M
|
![]() Switzerland
|
![]() Bausch Health
BHC
|
$1.67 B |
-0.000 M
|
![]() Canada
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
Market Cap | = | ALDX Stock Price | * | ALDX Shares Outstanding |
= | $2.20 | * | 59.71 M | |
= | $0.13 B |